Prosecution Insights
Last updated: October 04, 2026
Application No. 18/838,425

ANCHORING SYSTEM FOR VASCULAR IMPLANTS

Non-Final OA §102§112
Filed
Aug 14, 2024
Priority
Feb 18, 2022 — DE 10 2022 103 887.4 +1 more
Examiner
DUDDEN, TERESA MARIE
Art Unit
Tech Center
Assignee
Stental GmbH
OA Round
1 (Non-Final)
48%
Grant Probability
Moderate
1-2
OA Rounds
1y 8m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 48% of resolved cases
48%
Career Allowance Rate
13 granted / 27 resolved
-11.9% vs TC avg
Strong +45% interview lift
Without
With
+45.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
49 currently pending
Career history
75
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
52.3%
+12.3% vs TC avg
§102
20.2%
-19.8% vs TC avg
§112
24.0%
-16.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 27 resolved cases

Office Action

§102 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim 8 objected to because of the following informalities: "the vascular implant is a vascular implant covered with a membrane" should read "the vascular implant is covered with a membrane". Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-10 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 1-6 recite the limitation "anchoring system" in line 1. There is insufficient antecedent basis for this limitation in the claim. Dependent claims 7-10 are likewise rejected. Claims 3 and 6 recite the limitation "the lumen" in line 2. There is insufficient antecedent basis for this limitation in the claim. Claims 2 and 6 recite the limitation "the vascular implant" in line 2 (claim 3) and lines 2-3 (claim 6). There is insufficient antecedent basis for this limitation in the claim. Claim 6 recites the limitation "the chord" in line 4. There is insufficient antecedent basis for this limitation in the claim. Claims 7-10 recite the limitation "Vascular implant" in line 1. There is insufficient antecedent basis for this limitation in the claim. Claim 7 recites the limitation "an anchoring system" in line 1. There is insufficient antecedent basis for this limitation in the claim. Claim 9 recites the limitation "the distal region" in line 3. There is insufficient antecedent basis for this limitation in the claim. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-10 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Chuter (US 7,135,037 B1). Regarding claim 1, Chuter teaches an anchoring system for vascular implants comprising a plurality of anchoring elements in the form of threads and/or sutures and/or knots (58, flexible thread, 59, connectors, fig. 4) formed from threads (col 4 lines 32-51), which are at least partially provided on the inside of vascular implant (fig. 4). Regarding claim 2, Chuter further teaches the anchoring elements are arranged in a ring- and/or helical-shaped configuration (fig. 4, it is understood the flexible tread and connectors would encircle the interior of the implant). Regarding claim 3, Chuter further teaches the sutures have loops that extend into the lumen of the vascular implant (59, connectors, fig. 4). Regarding claim 4, Chuter further teaches the knots arranged in a ring form a polygon, in particular a hexagon or octagon (fig. 4 shows 4 knots on one ½ of the implant, it is further inferred there would be 8 total knots on the interior of the implant). Regarding claim 5, Chuter further teaches at least some of the knots are connected to each other by threads (58, flexible thread, fig. 4). Regarding claim 6, Chuter further teaches the threads pass through the lumen of the vascular implant in such a way that, in conjunction with the knots between which they run and the associated section of the vascular implant, they form an arc with the thread forming the chord (fig. 4). Regarding claim 7, Chuter further teaches a vascular implant with an anchoring system according to claim 1(fig. 3). Regarding claim 8, Chuter further teaches the vascular implant is a vascular implant covered with a membrane (fig. 3, covered expandable stent). Regarding claim 9, Chuter further teaches the covered vascular implant is a multilumen implant having a main lumen (21, trunk, fig. 3) and at least two secondary lumens (22, 23, legs, fig. 3), and wherein the anchoring system is arranged in the distal region of at least one of the secondary lumens (fig. 3). Regarding claim 10, Chuter further teaches the anchoring system is provided on the membrane (fig. 4). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to TERESA M DUDDEN whose telephone number is (571)272-0435. The examiner can normally be reached Monday - Friday 7:30 am - 5:00 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, JERRAH C EDWARDS can be reached at 408-918-7557. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /T.M.D./Examiner, Art Unit 3774 /YASHITA SHARMA/Primary Patent Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

Aug 14, 2024
Application Filed
Sep 01, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12714553
INTRAOCULAR LENS WITH FOCAL PERFORMANCE TAILORED TO PUPIL SIZE DEPLOYING REFRACTIVE POWER MODIFICATION ALONG SPIRAL TRACKS
4y 3m to grant Granted Aug 25, 2026
Patent 12653673
ANNULAR AUGMENTATION DEVICE FOR CARDIAC VALVE REPAIR
5y 3m to grant Granted Jun 16, 2026
Patent 12648854
ARTIFICIAL JOINT STEM
3y 6m to grant Granted Jun 09, 2026
Patent 12594167
HIP IMPLANT SYSTEM
3y 4m to grant Granted Apr 07, 2026
Patent 12589015
STENT DELIVERY SYSTEM, ENDOSCOPE SYSTEM, AND STENT INDWELLING METHOD
3y 7m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
48%
Grant Probability
93%
With Interview (+45.2%)
3y 10m (~1y 8m remaining)
Median Time to Grant
Low
PTA Risk
Based on 27 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month